Categories: CancerNews

RaySearch Laboratories: Year-end report 2024

STOCKHOLM, Feb. 21, 2025 /PRNewswire/ —

FOURTH QUARTER (OCTOBER – DECEMBER 2024)

  • Order intake SEK 305.0 M (317.7)
  • Net sales SEK 322.7 (299.6) 
  • Operating profit SEK 73.6 M (44.4)
  • Profit after tax SEK 60.0 M (31.5)
  • Earnings per share before/after dilution SEK 1.75 (0.92)
  • Cash flow from operating activities SEK 102.9 M (115.8) 
  • Order backlog SEK 1,813.2 M (1,864.4) at the end of the period.

TWELVE MONTHS (JANUARY – DECEMBER 2024)

  • Order intake SEK 1,087.2 M (1,004.2)
  • Net sales SEK 1,192.0 M (1,022.2)
  • Operating profit SEK 260.5 M (114.9)
  • Profit after tax SEK 203.5 M (81.6)
  • Earnings per share before/after dilution SEK 5.94 (2.38)
  • Cash flow from operating activities SEK 485.2 M (455.9)
  • The Board of Directors proposes a dividend for the full-year 2024 of SEK 3.00 (0.70).

SIGNIFICANT EVENTS DURING THE FOURTH QUARTER

  • GenesisCare UK has placed an order for RayStation.
  • Number of radiotherapy clinics in China using RayStation now exceeds 100.
  • Three centers in the French Unicancer network select RayStation.
  • Institut Curie in France select RayStation for treatment planning with protons.
  • RayStation is in clinical use for proton-arc therapy at Trento Proton Therapy Center in Italy.

SIGNIFICANT EVENTS AFTER THE END OF THE REPORTING PERIOD

  • In January the Polish company Medim placed an order for the product DrugLog.
  • In October 2024, Nina Grönberg was appointed new CFO for RaySearch Laboratories AB (publ), Nina took up her position January 27.

FOR FURTHER INFORMATION, PLEASE CONTACT:
Johan Löf, CEO, Tel: +46 8 510 530 00, e-mail: johan.lof@raysearchlabs.com
Nina Grönberg, CFO, Tel: +46 8 510 530 00, e-mail: nina.gronberg@raysearchlabs.com

The information contained in this year-end report is such that RaySearch Laboratories AB (publ) is obliged to disclose under the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was submitted for publication on February 21, 2025, at 7:45 a.m.

WEBCAST

CEO Johan Löf and CFO Nina Grönberg will present RaySearch’s year-end report for January-December 2024 at a webcast to be held in English on Friday, February 21, 2025, at 10:00-10:30 a.m. CET.

Link to webcast: RaySearch Year-end report 2024

This information was brought to you by Cision http://news.cision.com.

https://news.cision.com/raysearch-laboratories/r/year-end-report-2024,c4109202

The following files are available for download:

 

View original content:https://www.prnewswire.com/news-releases/raysearch-laboratories-year-end-report-2024-302382164.html

SOURCE RaySearch Laboratories

Staff

Recent Posts

The Doctor and The Athlete: Powerhouse Duo Disrupts Functional Beverage Market with Science-Backed “Happiness”

TAMPA, Fla., Feb. 2, 2026 /PRNewswire/ -- Happy Panda announces its official market launch with a…

53 minutes ago

FUGO Precision 3D to Debut Revolutionary Centrifugal 3D Printing Technology with Live Demonstrations at LMT LAB DAY Chicago 2026

GARDENA, Calif., Feb. 2, 2026 /PRNewswire/ -- FUGO Precision 3D, developer of the world's first all-in-one…

53 minutes ago

The Micro-Mechanics of Modern Oral Care

OXNARD, CA / ACCESS Newswire / February 2, 2026 / Quality Dental Services functions as…

4 hours ago

Dr. Shahrooz Yazdani Launches $6M Dental Practice Seminar Series to Help Owners Break Free from Burnout

Seminar offers step-by-step blueprint to grow your clinic, build passive income, and regain personal timeOTTAWA,…

7 hours ago

New Aura and UNC-Chapel Hill Study Finds One in Three Kids Have Accessed GenAI Apps

BOSTON, Feb. 2, 2026 /PRNewswire/ -- Aura, a leading AI-powered online safety platform for families,…

7 hours ago

‘Breathable’ Launches to Bring Hope and Humanity Back to Mental Health Care

New online network makes it simple, affordable and stigma-free to connect with licensed therapistsDETROIT, Feb.…

7 hours ago